Cue Biopharma (CUE) Return on Equity [ROE] (2018 - 2026)
Cue Biopharma's Return on Equity [ROE] came in at -709.39% for Q2 2026, down 391.01 percentage points from -318.38% a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Cue Biopharma's Return on Equity [ROE] was -123.16%, up 28.90 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -56.06 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -152.06% in FY2024 (-50.57 pp), -101.49% in FY2023 (-20.67 pp), -80.82% in FY2022 (-19.66 pp) and -61.16% in FY2021 (+5.93 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q1 2018.
- Year-over-year, Return on Equity [ROE] increased in 1 of the last seven quarters, with an average year-over-year change of -119.56 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2025 (a gain of 59.79 percentage points), and the weakest in Q2 2026 (a drop of 391.01 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 4.97% |
| 10 | Cue Biopharma | 98.78 Mn | 8.05 Mn | - | -709.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -709.39% |
| Dec 31, 2025 | -133.83% |
| Sep 30, 2025 | -243.03% |
| Jun 30, 2025 | -318.38% |
| Mar 31, 2025 | -341.63% |
| Dec 31, 2024 | -193.63% |
| Sep 30, 2024 | -194.51% |
| Jun 30, 2024 | -187.00% |
| Mar 31, 2024 | -153.26% |
| Dec 31, 2023 | -130.78% |
| Sep 30, 2023 | -119.95% |
| Jun 30, 2023 | -104.77% |
| Mar 31, 2023 | -87.32% |
| Dec 31, 2022 | -92.03% |
| Sep 30, 2022 | -84.34% |
| Jun 30, 2022 | -77.91% |
| Mar 31, 2022 | -69.88% |
| Dec 31, 2021 | -67.80% |
| Sep 30, 2021 | -68.51% |
| Jun 30, 2021 | -61.37% |
API Access
Cue Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();